Implementation of risk-sharing contracts as perceived by Spanish hospital pharmacists
Author:
Funder
Ministerio de Economía y Competitividad
Publisher
Springer Science and Business Media LLC
Subject
Health Policy
Link
http://link.springer.com/content/pdf/10.1186/s13561-019-0242-x.pdf
Reference36 articles.
1. Towse A, Garrison LP. Can’t get no satisfaction? Will pay for performance help? Toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products. Pharmacoeconomics. 2010;28(2):93–102.
2. Toumi M. ZardJ, Duvillard R, Jonmi C. lnnovative medicines and market access agreements. Annales Pharmaceutiques Francaises. 2013;71(5):302–25.
3. Carlson JJ, Sullivan SD, Garrison LP, Neumann PJ, Veenstra DL. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy. 2010;96:179–90.
4. Garrison LP Jr, Towse A, Briggs A, De Pouvourville G, Grueger J, Mohr PE, et al. Performance-based risk-sharing arrangements –good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force. Value Health. 2013;16(5):703–19.
5. Adamski J, Godman B, Ofierska-Sujkowska G, Osiska B, Herholz H, Wendykowska K, Laius O, Jan S, Sermet C, Zara C, Kalaba M, Gustafsson, Garuoliene K, Haycox A, Garattini S, Gustafsson LL. Risk sharing arrangements for pharmaceuticals: Potential considerations and recommendations for European payers. BMC Health Serv Res. 2010;10:153.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Agreement and MOU: Ethical and Legal Aspects of Funding for Healthcare Research;Grant writing for medical and healthcare professionals;2023
2. The Challenges of Outcomes-Based Contract Implementation for Medicines in Europe;PharmacoEconomics;2021-09-04
3. Payer perceptions of the use of real-world evidence in oncology-based decision making;Journal of Managed Care & Specialty Pharmacy;2021-08
4. Characterization of the Pharmaceutical Risk-Sharing Arrangement Process in Catalonia;PharmacoEconomics;2021-06-10
5. How Risky Is That Risk Sharing Agreement? Mean-Variance Tradeoffs and Unintended Consequences of Six Common Risk Sharing Agreements;MDM Policy & Practice;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3